A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, Harald Prüß, S. Momsen Reincke et al.|Cell|2020Cited by 387
Virus-induced senescence is a driver and therapeutic target in COVID-19Soyoung Lee, Clemens A. Schmitt, Adolfo García‐Sastre et al.|Nature|2021Cited by 344
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian HamstersNikolaus Osterrieder, Jakob Trimpert, Luca D. Bertzbach et al.|Viruses|2020Cited by 243
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19Geraldine Nouailles, Martin Witzenrath, Emanuel Wyler et al.|Nature Communications|2021Cited by 101
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 InfectionJakob Trimpert, Nikolaus Osterrieder, Daria Vladimirova et al.|Cell Reports|2020Cited by 100